Processa Pharmaceuticals, Inc. quarterly report, Q2 FY2013

Business Context and Reporting Period

Company: Heatwurx, Inc. (Note: Input metadata referenced "Processa Pharmaceuticals," but the filing text identifies the registrant as Heatwurx, Inc., a development-stage asphalt repair equipment company).

Reporting Period: Quarterly report (Form 10-Q) for the period ended June 30, 2013.

Business Overview: The Company designs, manufactures, and distributes asphalt repair machinery using an eco-friendly hot-in-place recycling process. It is classified as a development-stage company with limited revenue history.

Key Financial Metrics

Metric Six Months Ended June 30, 2013 Six Months Ended June 30, 2012
Total Revenue $116,480 $111,636
Gross Profit $42,830 $45,403
Net Loss $(1,542,936) $(1,055,716)
Cash and Cash Equivalents (End of Period) $629,804 $2,130,825
Working Capital Deficit $(1,427,116) Not explicitly stated (Current Assets $1,157,043 vs Current Liabilities $715,652)
Accumulated Deficit $(5,032,622) $(3,430,807)
Current Debt Obligations $2,017,666 (Notes Payable due within 12 months) $527,218

Material Changes vs. Prior Period

  • Revenue: Increased slightly by approximately $4,800 (4.3%) compared to the prior six-month period, driven by equipment sales.
  • Expenses: Selling, general, and administrative (SG&A) expenses surged to $1,402,171 from $690,378, primarily due to increased employee costs ($183,000), advertising ($247,000), and depreciation/amortization ($204,000).
  • Net Loss: Widened significantly to $1.54 million from $1.06 million due to the sharp increase in operating expenses.
  • Liquidity: Cash on hand decreased by approximately $397,671 to $629,804. The Company utilized $1.37 million in cash for operating activities.
  • Debt Structure: The Company incurred $990,087 in new senior secured notes payable in May 2013, maturing September 15, 2013. Current liabilities increased substantially due to the reclassification of long-term debt to current maturities.

Outlook, Risks, and Management Commentary

  • Going Concern: Management explicitly states that the Company's financial condition raises substantial doubt about its ability to continue as a going concern. The Company has an accumulated deficit of over $5 million and a working capital deficit of $1.4 million.
  • Cash Burn: The Company is spending approximately $250,000 per month. Current cash reserves ($630,000) are insufficient to fund operations for the next 12 months without additional financing.
  • Financing Needs: Management anticipates a need to secure up to $4.5 million over the next 12 months to meet cash flow requirements and repay secured debt maturing in late 2013 and early 2014.
  • Capital Raise: On June 21, 2013, the Company initiated an offering of 1.5 million units (Series D Preferred Stock and warrants) at $3.00 per unit. As of August 6, 2013, $953,490 in gross proceeds had been raised.
  • Risks: Key risks include the inability to obtain additional financing, failure to achieve revenue targets for performance stock options, and dependence on a small group of investors.

Investor Verification Checklist

  • Debt Maturity Wall: Verify the Company's ability to repay $1,000,000 in senior secured notes due September 15, 2013, and $1,000,000 in senior subordinated notes due between October 2013 and April 2014.
  • Capital Raise Progress: Confirm the status of the Series D Preferred Stock offering and whether the full $4.5 million target has been or will be achieved.
  • Revenue Run Rate: Assess if the current revenue trajectory (~$116k per six months) is sufficient to support the current cost structure of ~$250k/month.
  • Preferred Stock Conversions: Review the impact of recent conversions of Series A, B, and C preferred stock to common stock on dilution and liquidation preferences.
  • Related Party Transactions: Note the $94,800 in consulting fees paid to founder Richard Giles during the six-month period.